Harrow, Inc. (Harrow Health, Inc.) - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed on March 4, 2019, by Harrow Health, Inc., a Delaware corporation. The report serves as a current disclosure pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a procedural filing to disclose a corporate presentation and does not contain audited financial statements or quarterly results.
Material Changes
No material changes to financial performance or operations are reported in this document. The filing is limited to the disclosure of a corporate presentation used by management at investor conferences.
Guidance, Outlook, and Risks
Item 7.01 discloses a corporate presentation (Exhibit 99.1) dated March 2019. The filing explicitly states that the information contained in the presentation is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly referenced. Consequently, no specific guidance, outlook, or risk factors are detailed within the text of this 8-K.
Key Facts for Investor Verification
- Verify the content of the attached Exhibit 99.1 (Corporate Presentation) for any forward-looking statements or strategic updates, noting these are not legally "filed" within this 8-K.
- Confirm that no financial data is included in this specific filing; investors should refer to the most recent 10-K or 10-Q for financial metrics.
- Note the filing date of March 4, 2019, and the signatory, Andrew R. Boll, Chief Financial Officer.